Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Δουλάμη, Ιορδανία
DOB:	07-JUL-1976 (Age: 49)
Gender:	female
Address:	Μεσιανής 0 291 00 Ζάκυνθος (Greece)
ID:	8835-942848-4 (ECI)

Report
Date:	06-JUN-2025

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Dr. Aggeliki Papadopoulos 130 Odós Mitropoleos 291 00 Zakynthos (Greece)

Specimen
Collected:	06-JUN-2025

Chemistry

Test	06-JUN-2025	Reference Range	Unit
Hemoglobin [Presence] in Stool from gastrointestinal lower by Immunoassay --1st specimen	17.6	0 - 50	ng/mL

Cancer pathology panel

Test	06-JUN-2025	Reference Range	Unit
Polyp size greatest dimension	5.9	0 - 10	mm

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Both the detected polyp size (5.9 mm) and fecal hemoglobin (17.6 ng/mL) are within normal limits. No laboratory evidence of gastrointestinal bleeding or abnormal polyp size at this time. Recommend routine surveillance as clinically indicated.